EPS survey – pharmacy teams, please share your views

EPS_release2_21_hr

THIS CONTENT HAS NOW EXPIRED

EPS survey – pharmacy teams, please share your views

February 2, 2016

PricewaterhouseCoopers (PwC) is conducting an independent assessment of the costs, systems and usage of the Electronic Prescription Service (EPS) in community pharmacies. This work is being undertaken on behalf of HSCIC, along with PSNC, NHS England and NHS Employers.

All pharmacy staff can now take part in this work by completing PwC’s online EPS survey by Friday 19th February 2016; it will take around 10 minutes to complete. PwC would like input from all community pharmacy team members, therefore multiple members of staff at each pharmacy can complete the survey if they wish. Staff at multiple head offices may also complete the survey in relation to specific pharmacies.

If you have any questions about the survey, please contact Callum Foster, PwC Project Senior Manager, on 0191 269 4221, or PSNC EPS Lead Daniel Ah-Thion.

Why is this work important for pharmacy teams?

This work is vital to ensure that any additional costs associated with the use of EPS can be assessed and then considered in future funding negotiations. PSNC therefore encourages pharmacy team members to complete the survey and make sure their experience of using EPS is heard.

The survey is part of a larger piece of work that was agreed with NHS England as part of the 2015/16 community pharmacy contractual framework funding settlement; find out more at: psnc.org.uk/our-news/eps-costing-study-commences



Posted in:


More Latest News >

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...

EPS nomination – core principles

This briefing provides pharmacy teams with information about the core principles of Electronic Prescription Service (EPS) Nomination. PSNC Briefing 034/16:...

July CPN is now online

The July edition of PSNC’s Community Pharmacy News is now available. This month’s CPN features: Pharmacy gains third party support...